{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:51:33Z","timestamp":1760982693009},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.pnpbp.2008.08.013","type":"journal-article","created":{"date-parts":[[2008,8,29]],"date-time":"2008-08-29T12:46:15Z","timestamp":1220013975000},"page":"1844-1847","source":"Crossref","is-referenced-by-count":28,"title":["Manganese superoxide dismutase gene Ala\u20139Val polymorphism might be related to the severity of abnormal involuntary movements in Korean schizophrenic patients"],"prefix":"10.1016","volume":"32","author":[{"given":"Seung-Gul","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Eun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyonggin","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heon-Jeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changsu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Ku","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Nam","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sook-Haeng","family":"Joe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Kwa","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leen","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2008.08.013_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pnpbp.2004.10.014","article-title":"Association between Ala\u20139Val polymorphism of Mn-SOD gene and schizophrenia","volume":"29","author":"Akyol","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/sj.mp.4002142","article-title":"Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions","volume":"13","author":"Bakker","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0006-3223(97)00197-2","article-title":"Vitamin E, lipids, and lipid peroxidation products in tardive dyskinesia","volume":"43","author":"Brown","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib4","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0149-7634(94)90001-9","article-title":"Free radical mechanisms in schizophrenia and tardive dyskinesia","volume":"18","author":"Cadet","year":"1994","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib5","series-title":"The History and Geography of Human Genes","author":"Cavalli-Sforza","year":"1994"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/oxfordjournals.schbul.a033414","article-title":"Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E","volume":"25","author":"Elkashef","year":"1999","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/9780470122860.ch2","article-title":"Superoxide dismutases","volume":"41","author":"Fridovich","year":"1974","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib8","series-title":"ECDEU Assessment Manual for Psychopharmacology","first-page":"534","article-title":"Abnormal Involuntary Movement Scale (AIMS)","author":"Guy","year":"1976"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib9","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1111\/j.1753-4887.1997.tb06100.x","article-title":"Antioxidants and human disease: a general introduction","volume":"55","author":"Halliwell","year":"1997","journal-title":"Nutr Rev"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib10","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorder\u2014Korean Version","author":"Han","year":"2000"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib11","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1006\/bbrc.1999.1036","article-title":"Polymorphisms in the SOD2 and HLA\u2013DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese","volume":"261","author":"Hiroi","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib12","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.pnpbp.2006.12.019","article-title":"Association between the MnSOD Ala\u20139Val polymorphism and development of schizophrenia and abnormal involuntary movements in the Xhosa population","volume":"31","author":"Hitzeroth","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0893-133X(99)00156-6","article-title":"Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia","volume":"23","author":"Hori","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/schbul\/19.2.303","article-title":"Tardive dyskinesia","volume":"19","author":"Jeste","year":"1993","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib15","doi-asserted-by":"crossref","first-page":"52S","DOI":"10.1097\/00004714-198808001-00010","article-title":"Tardive dyskinesia: prevalence, incidence, and risk factors","volume":"8","author":"Kane","year":"1988","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib16","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.pnpbp.2008.05.016","article-title":"No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients","volume":"32","author":"Kang","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000123118","article-title":"Val158Met polymorphism in the catechol-O-methyltransferase (COMT) gene is not associated with tardive dyskinesia in schizophrenia","volume":"57","author":"Kang","year":"2008","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib19","first-page":"66","article-title":"Pharmacogenetic studies investigating the adverse effects of antipsychotics","volume":"4","author":"Lee","year":"2007","journal-title":"Psychiatr Invest"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000103576","article-title":"No association between dopamine D4 receptor gene \u2212521 C\/T polymorphism and tardive dyskinesia in schizophrenia","volume":"55","author":"Lee","year":"2007","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/hup.875","article-title":"No evidence for an association between G protein \u03b23 subunit gene C825T polymorphism and tardive dyskinesia in schizophrenia","volume":"22","author":"Lee","year":"2007","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0006-3223(90)90490-S","article-title":"Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia","volume":"28","author":"Lohr","year":"1990","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1034\/j.1600-0447.2001.00401.x","article-title":"Familial occurrence of tardive dyskinesia","volume":"104","author":"M\u00fcller","year":"2001","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.psychres.2006.04.011","article-title":"Manganese superoxide dismutase (MnSOD: Ala\u20139Val) gene polymorphism may not be associated with schizophrenia and tardive dyskinesia","volume":"153","author":"Pae","year":"2007","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/1028415021000033767","article-title":"Role of oxidative stress and antioxidants in neurodegenerative diseases","volume":"5","author":"Rao","year":"2002","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib26","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1023\/A:1005427323835","article-title":"The role of manganese superoxide dismutase in health and disease","volume":"21","author":"Robinson","year":"1998","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib27","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0091-3057(94)90085-X","article-title":"Possible genetic factors underlying the pathophysiology of tardive dyskinesia","volume":"49","author":"Rosengarten","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archpsyc.1982.04290040080014","article-title":"Research diagnosis for tardive dyskinesia","volume":"39","author":"Schooler","year":"1982","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib29","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2165\/00003495-199652060-00006","article-title":"Pharmacological options for the management of dyskinesias","volume":"52","author":"Shale","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1006\/bbrc.1996.1394","article-title":"Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease","volume":"226","author":"Shimoda-Matsubayashi","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib31","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1212\/WNL.49.5.1257","article-title":"Mn SOD activity and protein in a patient with chromosome 6-linked autosomal recessive parkinsonism in comparison with Parkinson's disease and control","volume":"49","author":"Shimoda-Matsubayashi","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib32","first-page":"431","article-title":"The pathophysiologic basis of tardive dyskinesia","volume":"12","author":"Tarsy","year":"1977","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib33","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/mds.20823","article-title":"Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?","volume":"21","author":"Tarsy","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib34","first-page":"165","article-title":"Familial occurrence of tardive dyskinesia","volume":"42","author":"Weinhold","year":"1981","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib35","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1176\/ajp.138.12.1618","article-title":"Familial tardive dyskinesia","volume":"138","author":"Yassa","year":"1981","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib36","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/schbul\/18.4.701","article-title":"Gender differences in tardive dyskinesia: a critical review of the literature","volume":"18","author":"Yassa","year":"1992","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3956(02)00007-9","article-title":"The increased activity of plasma manganese superoxide dismutase in tardive dyskinesia is unrelated to the Ala\u20139Val polymorphism","volume":"36","author":"Zhang","year":"2002","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2008.08.013_bib38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00041444-200309000-00010","article-title":"Interaction between polymorphisms of the dopamine D3 receptor and manganese superoxide dismutase genes in susceptibility to tardive dyskinesia","volume":"13","author":"Zhang","year":"2003","journal-title":"Psychiatr Genet"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584608002509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584608002509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T14:41:55Z","timestamp":1709217715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584608002509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0278584608002509"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2008.08.013","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}